ArticleOncotarget2018

Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia.

Laurie Freire Boullosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.